Journal
BONE MARROW TRANSPLANTATION
Volume 27, Issue 1, Pages 15-20Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1702731
Keywords
ATL; allo-SCT; allo-BMT; allo-PBSCT; HTLV-I proviral DNA
Categories
Ask authors/readers for more resources
Adult T cell leukemia/lymphoma (ATL) is a poor prognosis T cell malignancy. In order to improve the outcome, we employed allogeneic stem cell transplantation (allo-SCT) for ATL in 10 patients, nine of whom were from HLA-identical siblings and one from an unrelated donor, Conditioning regimens varied among the patients except that all received total body irradiation. The patients tolerated the regimens well with mild, if any toxicity, and engraftment occurred in all cases. Median leukemia-free survival after allo-SCT was 17.5+ months (range 3,7-34,4+), Six of the 10 patients developed acute GVHD tone case each with grade I, III or IV, and three cases with grade II) and three patients developed extensive chronic GVHD, Four patients died after allo-SCT during the study period from either acute GVHD (grade IV), pneumonitis, gastrointestinal bleeding or renal insufficiency. Two of the 10 cases with no symptoms of GVHD relapsed with clinical ATL, These results strongly suggest that allo-SCT may improve the survival in ATL if a controlled degree of GVHD develops.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available